Table Of Contents

1. Introduction 70
1.1. Objectives Of The Study 70
1.2. Market Definition 70
1.3. Overview Of Global Bio-Implants Market 70
1.4. Currency And Pricing 72
1.5. Limitation 72
1.6. Markets Covered 73
2. Market Segmentation 77
2.1. Markets Covered 77
2.2. Geographic Scope 78
2.3. Years Considered For The Study 79
2.4. Currency And Pricing 79
2.5. Research Methodology 80
2.6. Primary Interviews With Key Opinion Leaders 83
2.7. Secondary Sources 84
2.8. Assumptions 84
3. Market Overview 85
3.1. Drivers 87
3.1.1. Rising Number Of Aging And Geriatric Population 87
3.1.2. Changing Lifestyle Problems 87
3.1.3. Rising Incidence Of Chronic Diseases 88
3.1.4. Increasing Awareness About Cosmetic Implants 89
3.1.5. Technological Advancement In Implants 90
3.1.6. Rising Demand For Non-Surgical Bio-Implants 90
?
3.2. Restraints 91
3.2.1. High Cost Of Implants 91
3.2.2. Regulatory Scenario 91
3.2.3. Unfavourable Reimbursement Policies 92
3.3. Opportunities 93
3.3.1. Emerging Inclination For Mis Surgeries 93
3.3.2. Growing Number Of Diagnostic Centers And Clinics 94
3.3.3. Emerging Countries 94
3.3.4. Rising Medical Tourism 95
3.4. Challenges 96
3.4.1. Side-Effects Of Various Cosmetic Surgery 96
3.4.2. Lack Of Trained Professionals 96
4. Executive Summary 97
5. Premium Insights 101
6. Global Bio-Implants Market, By Product Type 104
6.1. Overview 105
6.2. Orthopedics & Trauma 107
6.2.1. Reconstructive Joint Replacements 109
6.2.1.1. Knee Replacement Implants 109
6.2.1.2. Hip Replacement Implants 109
6.2.1.3. Extremities 110
6.2.2. Orthobiologics 112
6.2.2.1. Hyaluronic Acid 112
6.2.2.2. Bone Substitutes 113
6.2.2.3. Bone Growth Factors 113
6.2.2.4. Tissue Implants 113
6.2.2.5. Bone Cement 113
?
6.2.3. Trauma Implants 114
6.2.3.1. Internal Trauma Fixation Devices 114
6.2.3.2. Craniomaxillofacial Fixation Devices 114
6.2.3.3. Implantable Trauma Stimulators 115
6.2.4. Sports Medicine 115
6.3. Pacing Devices 115
6.3.1. Cardiac Resynchronization Therapy Devices (Crtd) 116
6.3.2. Implantable Cardioverter Defibrillators (Icd) 117
6.3.3. Implantable Cardiac Pacemakers (Icp) 117
6.3.3.1. Single Chambered 118
6.3.3.2. Dual Chambered 118
6.3.3.3. Multiple Chambered 118
6.3.4. Pacing Accessories 118
6.3.4.1. Pacing Leads 119
6.3.4.2. Pacing Batteries 119
6.4. Stents & Related Implants 119
6.4.1. Coronary Stents 121
6.4.1.1. Drug-Eluting Stents 121
6.4.1.2. Bare-Metal Coronary Stents 122
6.4.1.3. Bioabsorbable Stents 122
6.4.2. Peripheral Stents 122
6.4.2.1. Endovascular Stent-Grafts 123
6.4.2.2. Renal & Related Stents 123
6.4.2.3. Femoral & Related Stents 123
6.4.2.4. Carotid Stents 123
6.4.3. Stent-Related Implants 124
6.4.3.1. Synthetic Grafts 124
6.4.3.2. Vascular Grafts 125
6.4.3.3. Peripheral Grafts 125
6.4.3.4. Vena Cava Filters 125
6.5. Spinal Implants 126
6.5.1. Thoracolumbar Implants 127
6.5.2. Intervertebral Spacers 127
6.5.3. Machined Allograft Spacers 128
6.5.4. Cervical Implants 128
6.5.5. Motion Preservation Implants 128
6.5.6. Implantable Spinal Stimulators 128
6.6. Ophthalmic Implants 128
6.6.1. Intraocular Lens 130
6.6.2. Glaucoma & Other Lenses 130
6.7. Structural Cardiac Implants 130
6.7.1. Heart Valves & Accessories 132
6.7.2. Tissue Heart Valves 132
6.7.3. Mechanical Heart Valves 132
6.7.4. Heart Valve Repair Devices 132
6.7.5. Ventricular Assist Device (Vad) 132
6.7.6. Implantable Heart Monitors 133
6.7.7. Insertable Loop Recorders (Ilrs) 133
6.7.8. Implantable Hemodynamic Monitors (Ihm) 133
6.8. Dental Implants 134
6.8.1. Plate Form Dental Implants 135
6.8.2. Root Form Dental Implants 135
6.9. Neurostimulators Implants 136
6.9.1. Cortical Stimulators 137
6.9.2. Deep Brain Stimulators 137
6.9.3. Sacral Nerve Stimulators 137
6.9.4. Spinal Cord Stimulators 138
6.9.5. Vagus Nerve Stimulators 138
6.10. Prosthetic Implants 138
6.10.1. Osseointegration 139
6.10.2. Titanium-Based Prosthetic Implants 139
6.11. Others 140
6.11.1. Gynecological Devices 141
6.11.2. Drug Implants 141
6.11.3. Cosmetic Implants 142
6.11.4. Gastroenterological Implants 142
6.11.5. Urological Implants 142
6.11.6. Skin & Wound Care 142
6.11.7. Otolaryngeal Implants 142
7. Global Bio-Implants Market, By Type 143
7.1. Overview 144
7.2. Allograft 146
7.3. Autograft 147
7.4. Xenograft 148
7.5. Synthetic 149
7.6. Others 150
8. Global Bio-Implants Market, By Material 151
8.1. Overview 152
8.2. Biomaterial Metal 154
8.2.1. Titanium 155
8.2.2. Gold 155
8.2.3. Silver 155
8.2.4. Platinum 156
8.3. Alloy 156
?
8.4. Polymer 157
8.4.1. Natural Polymers 158
8.4.2. Synthetic Polymers 158
8.5. Ceramics 159
8.6. Acrylic Hydrogel 160
9. Global Bio-Implants Market, Mode Of Administration 161
9.1. Overview 162
9.2. Surgical 164
9.3. Non-Surgical 165
9.3.1. Injectable Fillers/Biomaterials 166
9.3.2. Osteogenic Injectable Bone Substitutes 166
9.3.3. Viscosupplementation 167
9.3.4. Viscoaugmentation 167
10. Global Bio-Implants Market, By End-User 168
10.1. Overview 169
10.2. Clinics 171
10.3. Hospitals 172
10.4. Ambulatory Surgical Centers 173
10.5. Others 174
11. Global Bio-Implants Market, By Geography 175
11.1. Overview 176
11.2. North America 183
11.2.1. U.S. 205
11.2.2. Canada 220
11.2.3. Mexico 235
11.3. Europe 250
11.3.1. Germany 272
11.3.2. France 287
11.3.3. U.K. 302
11.3.4. Italy 317
11.3.5. Spain 332
11.3.6. Switzerland 347
11.3.7. Netherlands 362
11.3.8. Belgium 377
11.3.9. Russia 392
11.3.10. Turkey 407
11.3.11. Rest Of Europe 422
11.4. Asia-Pacific 423
11.4.1. Japan 445
11.4.2. China 460
11.4.3. India 475
11.4.4. South Korea 490
11.4.5. Australia 505
11.4.6. Singapore 520
11.4.7. Thailand 535
11.4.8. Malaysia 550
11.4.9. Indonesia 565
11.4.10. Philippines 580
11.4.11. Rest Of Asia-Pacific 595
11.5. South America 596
11.5.1. Brazil 618
11.5.2. Rest Of South America 633
11.6. Middle East And Africa 634
11.6.1. South Africa 656
11.6.2. Rest Of Middle East And Africa 671
?
12. Global Bio-Implants Market, Company Landscape 672
12.1. Company Share Analysis; Global 672
12.2. Company Share Analysis; North America 673
12.3. Company Share Analysis; Europe 674
12.4. Company Share Analysis; Asia Pacific 675
13. Company Profiles 676
13.1. Medtronic 676
13.1.1. Company Overview 676
13.1.2. Revenue Analysis 677
13.1.3. Product Portfolio 678
13.1.4. Recent Developments 679
13.2. Johnson & Johnson Services, Inc. 680
13.2.1. Company Overview 680
13.2.2. Johnson & Johnson Services, Inc.; Revenue Analysis 680
13.2.3. Product Portfolio 681
13.2.4. Recent Developments 681
13.3. Edward Lifesciences Corporation 682
13.3.1. Company Overview 682
13.3.2. Edward Lifesciences Corporation ;Revenue Analysis 682
13.3.3. Product Portfolio 683
13.3.4. Recent Developments 683
13.4. Boston Scientific Corporation 684
13.4.1. Company Overview 684
13.4.2. Boston Scientific Corporation; Revenue Analysis 684
13.4.3. Product Portfolio 685
13.4.4. Recent Developments 685
?
13.5. Integra Lifesciences Corporation 686
13.5.1. Company Overview 686
13.5.2. Integra Lifesciences Corporation ;Revenue Analysis 686
13.5.3. Product Portfolio 687
13.5.4. Recent Developments 687
13.6. Abbott 688
13.6.1. Company Overview 688
13.6.2. Abbott ;Revenue Analysis 688
13.6.3. Product Portfolio 689
13.6.4. Recent Developments 689
13.7. C. R. Bard, Inc. 690
13.7.1. Company Overview 690
13.7.2. C. R. Bard, Inc.;Revenue Analysis 690
13.7.3. Product Portfolio 691
13.7.4. Recent Developments 691
13.8. Zimmer Biomet 692
13.8.1. Company Overview 692
13.8.2. Zimmer Biomet ;Revenue Analysis 692
13.8.3. Product Portfolio 693
13.8.4. Recent Developments 693
13.9. Biotronik Se & Co. Kg 694
13.9.1. Company Overview 694
13.9.2. Biotronik Se & Co. Kg ;Company Snapshot 694
13.9.3. Product Portfolio 695
13.9.4. Recent Developments 695
13.10. Lifenet Health, Inc. 696
13.10.1. Company Overview 696
13.10.2. Lifenet Health, Inc.;Company Snapshot 696
13.10.3. Product Portfolio 697
13.10.4. Recent Developments 697
13.11. Integrated Orbital Implants 698
13.11.1. Company Overview 698
13.11.2. Integrated Orbital Implants ;Company Snapshot 698
13.11.3. Product Portfolio 699
13.11.4. Recent Developments 699
13.12. Smith & Nephew 700
13.12.1. Company Overview 700
13.12.2. Smith & Nephew ;Revenue Analysis 700
13.12.3. Product Portfolio 701
13.12.4. Recent Developments 702
13.13. Stryker 703
13.13.1. Company Overview 703
13.13.2. Stryker ;Revenue Analysis 703
13.13.3. Product Portfolio 704
13.13.4. Recent Developments 704
13.14. W. L. Gore & Associates, Inc 705
13.14.1. Company Overview 705
13.14.2. W. L. Gore & Associates, Inc ;Company Snapshot 705
13.14.3. Product Portfolio 706
13.14.4. Recent Developments 706
13.15. Valeant Pharmaceuticals International Inc. 707
13.15.1. Company Overview 707
13.15.2. Valeant Pharmaceuticals International Inc.;Revenue Analysis 707
13.15.3. Product Portfolio 708
13.15.4. Recent Developments 708
?
13.16. Somnomed 709
13.16.1. Company Overview 709
13.16.2. Somnomed ;Revenue Analysis 709
13.16.3. Product Portfolio 710
13.16.4. Recent Developments 710
13.17. Wright Medical Group N.V. 711
13.17.1. Company Overview 711
13.17.2. Wright Medical Group N.V.;Revenue Analysis 711
13.17.3. Product Portfolio 712
13.17.4. Recent Developments 712
13.18. Livanova Plc 713
13.18.1. Company Overview 713
13.18.2. Livanova Plc ;Revenue Analysis 713
13.18.3. Product Portfolio 714
13.18.4. Recent Developments 714
13.19. St. Jude Medical, Inc. (A Subsidiary Of Abbott) 715
13.19.1. Company Overview 715
13.19.2. St. Jude Medical, Inc.;Company Snapshot 715
13.19.3. Product Portfolio 716
13.19.4. Recent Developments 716
13.20. Mimedx Group, Inc. 717
13.20.1. Company Overview 717
13.20.2. Mimedx Group, Inc.;Revenue Analysis 717
13.20.3. Product Portfolio 718
13.20.4. Recent Developments 718
?
13.21. Cook Group 719
13.21.1. Company Overview 719
13.21.2. Cook Group ;Company Snapshot 719
13.21.3. Product Portfolio 719
13.21.4. Recent Developments 719
14. Related Reports 720

?